Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Dow
Medtronic
McKesson
Baxter
Moodys

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Litigation Details for Monsanto Company v. Syngenta Seeds Inc. (D. Del. 2004)

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Monsanto Company v. Syngenta Seeds Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .
Biologic Drugs cited in Monsanto Company v. Syngenta Seeds Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Monsanto Company v. Syngenta Seeds Inc. (D. Del. 2004)

Date Filed Document No. Description Snippet Link To Document
2006-02-01 262 Exhibit 1-18 lnsect resistant cotton plants Biuchcltnology 8:939-943\ ll. Camu'r` N B.., W:rrten\G. W . Desai.… JUDGMENT OF NON-INFRINGEMENT OF THE LUNDQUIST PATENTS (VOLUME 1 OF 2)] by Monsanto Company, Monsanto … May 2004 23 May 2008 1:04-cv-00305 Patent District Court, D. Delaware External link to document
2006-02-10 293 Exhibit 16-22 5,352,605; 5,359,14?.; 5,424,2£}0; 5,5.‘:0,474; 5,614,399; EP342 925 Bl.; U.S. ‘r"at. No. 6,0?.0,190… States Patent Warsi et ah US 5,271,445 31 Aug, 7, 2001 (19) Patent No»: (45) Date of Patent: (54…United States Patent Chz'istou et al. (10) Patent No,: US 6,846,970 B]_ (45) Date of Patent: Jnn. 25,….: Sub_§:r.: to my discilzimcr. the term o{this patent is extended or adjusted unch 35 U.S .C. 154(b}…:: Subject to any disc!airner, the term of this patent is extended or adjusted under 35 usa 154{b) by External link to document
2008-05-19 603 Exhibit 1-15 Sorenson, John 5/25/2006 322:10 323:4 Stein, Jeffrey …Monsanto has misrepresented its patent position and disparaged Syngenta’s patent position relating to GA21 …). A patent holder is entitled to enforce its rights, including by sending patent notification…may infringe its patents, and such communication of accurate information about patent rights whether by… Aidun - Patent 4:16 4:17 Vahid Aidun - Patent External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Medtronic
Harvard Business School
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.